Literature DB >> 9753639

Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications.

M Qian1, M Liu, J W Eaton.   

Abstract

The present investigations arose from our interest in the possibility that some structures which arise secondary to protein glycation might bind transition metals such as iron and copper. In support of this we find that, when glycated, three different proteins--albumin, gelatin (a soluble collagen fragment) and elastin--all gain a substantial affinity for the transition metals iron and copper. The glycated proteins bind at least three times as much iron as do the non-glycated proteins. Similarly, glycated albumin and gelatin also bind 2-3 times as much copper. Furthermore, at least in the case of copper bound to glycated albumin, the bound metal retains redox activity and participates in the catalytic oxidation of ascorbic acid. Should similar "glycochelates" form in vivo in diabetics, reactions mediated by these chelates may be involved in certain complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753639     DOI: 10.1006/bbrc.1998.9326

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Transition metals redox: reviving an old plot for diabetic vascular disease.

Authors:  V M Monnier
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Preserving Brain Function in Aging: The Anti-glycative Potential of Berry Fruit.

Authors:  Nopporn Thangthaeng; Shibu M Poulose; Marshall G Miller; Barbara Shukitt-Hale
Journal:  Neuromolecular Med       Date:  2016-05-11       Impact factor: 3.843

3.  The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT).

Authors:  Francisco Ujueta; Ivan A Arenas; Esteban Escolar; Denisse Diaz; Robin Boineau; Daniel B Mark; Patrick Golden; Lauren Lindblad; Hwasoon Kim; Kerry L Lee; Gervasio A Lamas
Journal:  J Diabetes Complications       Date:  2019-04-14       Impact factor: 2.852

4.  The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT).

Authors:  Esteban Escolar; Gervasio A Lamas; Daniel B Mark; Robin Boineau; Christine Goertz; Yves Rosenberg; Richard L Nahin; Pamela Ouyang; Theodore Rozema; Allan Magaziner; Richard Nahas; Eldrin F Lewis; Lauren Lindblad; Kerry L Lee
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-11-19

5.  Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments.

Authors:  J Lu; D Gong; S Y Choong; H Xu; Y-K Chan; X Chen; S Fitzpatrick; S Glyn-Jones; S Zhang; T Nakamura; K Ruggiero; V Obolonkin; S D Poppitt; A R J Phillips; G J S Cooper
Journal:  Diabetologia       Date:  2010-03-11       Impact factor: 10.122

6.  Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy.

Authors:  John W Eaton; Mingwei Qian
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

7.  LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.

Authors:  J L Figarola; S Scott; S Loera; C Tessler; P Chu; L Weiss; J Hardy; S Rahbar
Journal:  Diabetologia       Date:  2003-07-05       Impact factor: 10.122

Review 8.  Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.

Authors:  Gervasio A Lamas; Ana Navas-Acien; Daniel B Mark; Kerry L Lee
Journal:  J Am Coll Cardiol       Date:  2016-05-24       Impact factor: 24.094

9.  Dissociation of functional status from accrual of CML and RAGE in the aged mouse brain.

Authors:  Nopporn Thangthaeng; Nathalie Sumien; Michael J Forster
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

10.  A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes.

Authors:  D Gong; J Lu; X Chen; S Reddy; D J Crossman; S Glyn-Jones; Y-S Choong; J Kennedy; B Barry; S Zhang; Y-K Chan; K Ruggiero; A R J Phillips; G J S Cooper
Journal:  Diabetologia       Date:  2008-07-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.